The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemoradiotherapy (nCRT) combined with sequential tislelizumab for resectable esophageal squamous cell carcinoma (ESCC): Preliminary results of a single-arm, open-label phase Ib trial (CRIS).
 
Youhua Jiang
No Relationships to Disclose
 
Guoqin Qiu
No Relationships to Disclose
 
Jianqiang Li
No Relationships to Disclose
 
Jiangfeng Wang
No Relationships to Disclose
 
Changchun Wang
No Relationships to Disclose
 
Jie Wu
No Relationships to Disclose
 
Lei Cheng
No Relationships to Disclose
 
Yuanda Zheng
No Relationships to Disclose
 
Rongwei Ruan
No Relationships to Disclose
 
Ge Song
No Relationships to Disclose
 
Xuemei Ye
No Relationships to Disclose